A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial

Table 2 Overview of data collection and measurements in both trial arms

	Baseline	Follow-up
Visit number	T0	T1	T2	T3
Time	Day 0	7 days post	6 weeks post	6 months post
Inclusion and exclusion criteria	X
Sociodemographic characteristics	X
SF-12	X			X
VES-13	X			X
MMSE	X
PATD	X			X
Blood glucose monitoring		X^c	X^c	X^c
Medication use characteristics	X
Benzodiazepine Tapering Questionnaire		X^a,b	X^a,b	X^a,b
DTSQs		X^c		X^c
Medication risk assessment	X	X
BMQ-Specific	X	X
Patient Self-Efficacy Scale	X	X		X
Intervention-related questionnaire		X	X	X
Intervention Appreciation Questionnaire				X

BMQ-Specific, Beliefs about Medicines Questionnaire - Specific segment [66]; DTSQs, Diabetes Treatment Satisfaction Questionnaire [67]; MMSE, Mini-Mental State Exam [68]; PATD, Patients Attitude Towards De-prescribing Questionnaire [69]; SF-12, 12-Item Short Form Survey to measure health status and health-related quality of life [70]; VES-13, Vulnerable Elders Survey [71]. ^aOnly administered if in benzodiazepine group
^bOnly administered if benzodiazepine tapering had begun
^cOnly administered if in sulfonylurea group

ISSN: 1745-6215